A White House proposal to subject research grants to political scrutiny meets at least a temporary roadblock in the Senate.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Get the inside view of the 2026 J.P. Morgan Healthcare Conference with STAT reporters on the ground. Hear the deals, data, and emerging themes shaping the year ahead, and leave with a clear sense of ...

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the ...

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...

The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain ...

In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...

Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...

Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections, ...

At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...